Eric Dillon's Journey: Overcoming Multiple Myeloma Through Resilience and Clinical Trials
When Eric Dillon first experienced shoulder pain, he attributed it to a strained rotator cuff. Despite initial relief from physical therapy and stretching, the discomfort persisted over the next two years. A sudden burst of intense pain during yard work prompted him to seek medical attention, leading to a shocking diagnosis of multiple myeloma, a type of blood cancer. The cancer had been causing his shoulder pain, which had been misdiagnosed as an injury. Multiple myeloma affects plasma cells and can lead to various complications, including anemia, kidney damage, and bone issues.
Dillon's diagnosis came as a surprise, but he was determined to start treatment promptly. He sought care at MD Anderson Cancer Center in Houston, where he received a treatment plan after confirming the diagnosis. Despite his shock, Dillon was familiar with the disease due to his cousin and a friend being affected by it. He learned that Black Americans are disproportionately impacted by multiple myeloma, with higher prevalence and earlier onset compared to other populations.
Eager to begin treatment, Dillon embraced the opportunity to participate in a clinical trial, viewing it as a chance to contribute to research and improve representation of Black patients in trials. He underwent eight cycles of treatment over nearly a year, adjusting his work schedule to accommodate the trial. Despite minor side effects, Dillon remained committed to the trial and was proud to have played a role in refining the treatment process.
Following the completion of the clinical trial, Dillon underwent additional rounds of radiation to eliminate remaining cancer in his shoulder bone, ultimately relieving him of the persistent pain. He is currently in remission, regularly monitoring his health with his oncologist and taking a daily medication to maintain his status. While a stem cell replacement may be a future consideration, Dillon is focused on cherishing moments with his family, including celebrating the arrival of a new grandchild.
In conclusion, Eric Dillon's journey with multiple myeloma highlights the importance of early detection, personalized treatment, and participation in clinical trials. Despite the challenges he faced, Dillon's resilience and proactive approach to his health have led him to a place of remission and gratitude for the moments he shares with his loved ones.